NCT06169007View on ClinicalTrials.gov

Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
Breast Cancer
All Listed Sponsors
lead

Assiut University

OTHER

NCT06169007 - Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer | Biotech Hunter | Biotech Hunter